Abstract:IL‐33 isoforms generated through allergen‐driven proteolysis, signal through NF‐κB at varying intensities. The magnitude of IL‐33 signalling is determined by asthma‐associated structural variation in IL33 receptor. Variation in the IL‐33 receptor extracellular domain alters accessibility of the IL‐33 ligand binding site. Introduction The interleukin‐33/interleukin‐1 receptor‐like‐1 (IL‐33/IL1RL1) signalling pathway is implicated in asthma pathogenesis, with IL1RL1 nonsynonymous genetic polymorphisms associated with disease risk. We aimed to determine these variants' effect on IL1RL1 signalling induced by different IL33 isoforms thought to be elevated in the asthmatic airway. Method In a project funded by GSK plc, which has developed an IL‐33 receptor inhibitor for asthma treatment, human embryonic kidney 293 (HEK293) cells expressing secreted embryonic alkaline phosphatase (SEAP) driven by a nuclear factor kappa‐beta (NF‐κB) promoter, were transiently transfected with IL1RL1, containing one of four extracellular and Toll/interleukin 1 receptor (TIR) domain haplotypes. Cells were stimulated with seven different splice and proteolytic‐generated IL‐33 isoforms (0.001–50 ng/mL) for 24 h. Supernatant SEAP activity and interleukin‐8 (IL‐8) levels were determined. Primary human bronchial epithelial cells (HBECs) representing different genotype carriers were stimulated with IL‐33112–270 (50 ng/mL) and induced IL‐8 mRNA expression measured. Results HEK293 cells carrying both asthma extracellular and TIR domain IL1RL1 risk haplotypes presented maximal IL33‐driven signalling, with minimal signalling after IL‐33 activation in other protective haplotypes. All IL‐33 isoforms activated IL1RL1 but with differing magnitudes. Proteolytically cleaved IL3395–270 and IL33106–270 had the greatest effect and the IL33113–270, and Exon 3,4 deletion isoform exhibited the lowest. The effect of extracellular and TIR domain genetic variants on receptor signalling was replicated in primary HBECs. Maximal IL1RL1 signalling was observed in cells carrying both extracellular and TIR signalling domain risk haplotypes. Conclusions Overall, our study suggests asthma patients carrying the extracellular and TIR domain risk haplotype and have a lung microenvironment that promotes elevated levels of cleaved IL33, particularly where IL3395–270 and IL33106–270 may be more amenable to IL33/IL1RL1 targeting.

IL-33 induced gene expression in activated Th2 effector cells is dependent on IL-1RL1 haplotype and asthma status

Phenotypic and functional translation of IL33 genetics in asthma

Epithelial Interleukin‐1 Receptor‐Like‐1 Activation Is Contingent on Interleukin‐33 Isoforms and Asthma‐Related Receptor Variation

Interleukin-31 Expression and Relation to Disease Severity in Human Asthma.

Interleukin-33-activated basophils promote asthma by regulating Th2 cell entry into lung tissue

Genetic variants of IL-13 signalling and human asthma and atopy

A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma

The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation

Interleukin (IL)-33 immunobiology in asthma and airway inflammatory diseases

Association of airway inflammation and smoking status with IL-33 level in sputum of patients with asthma or COPD

IL-33 amplifies airways inflammation in a murine surrogate of asthma possibly through acting on dendritic cells

The IL6R Gene Polymorphisms Are Associated with Sil-6R, IgE and Lung Function in Chinese Patients with Asthma.

Effect of genetic variation of IL-13 on airway remodeling in bronchial asthma

Sputum Transcriptomics Reveal Upregulation of IL-1 Receptor Family Members in Patients with Severe Asthma.

Endoplasmic reticulum stress drives macrophages to produce IL-33 to favor Th2 polarization in the airways

IL-33 released during challenge phase regulates allergic asthma in an age-dependent way

IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk

IL-4Rα signaling in CD4+CD25+FoxP3+ T regulatory cells restrains airway inflammation via limiting local tissue IL-33

The Effects of Th2 Cytokines on the Expression of ADAM33 in Allergen-Induced Chronic Airway Inflammation.

IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma

Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling